Services Agreement with Q-Gen for CAR19-iNKT manufacture
Filed with ASX · · 2 pages · English
Arovella Therapeutics Limited on 6ix
Earlier from Arovella Therapeutics
- Anagrelide patent for the United States
- Arovella Therapeutics: Proposed issue of securities - ALA
- Application for quotation of securities - ALA
- Update - Proposed issue of securities - ALA
- Arovella SPP Closed early over subscribed
Later from Arovella Therapeutics
- Adopts WEF Framework For ESG Reporting
- ZolpiMist Launch Australia
- Sumatriptan Update
- Quarterly Appendix 4C and Activities Report
- Preliminary Final Report
Follow Arovella Therapeutics into a list and get an email when it puts out news.
Follow Arovella Therapeutics